On the morning of August 19, 2026, leading officials from the Bureau of Biology of Chengdu High‑tech Zone visited Chengdu High‑tech Medical Association for a special research tour on the development of the "Yilu Kechuang Pioneer" Service Platform. Leading members of the Association’s leadership team and representatives from Chengdu Xingu Investment Group Co., Ltd. accompanied the research and attended the forum.

The research group first toured the "Yilu Pioneer · Sci‑tech Innovation Engine" Service Platform and watched the promotional video of the collaborative innovation center jointly built by Minshan Life Valley and the Association. They gained in‑depth insights into Party‑building‑led initiatives, platform functional layout, operational mechanisms and achievements in enterprise incubation. Subsequently, relevant persons‑in‑charge of the Association delivered a special report on the progress of the "Yilu Pioneer · Sci‑tech Innovation Engine" Service Platform, highlighting phased outcomes including incubator platform services plus CRO clinical transformation services, clinical trial and research translation businesses, the high‑level biomedicine industry incubator, and the development of an industrial exhibition and exchange window. Following the report, both sides held in‑depth discussions covering the implementation of the "Minshan Xinhuo" Initiative, optimization of achievement‑transformation mechanisms, coordinated investment and talent attraction, and improvement of enterprise‑service quality. The Association earnestly absorbed guidance from various divisions of the Bureau of Biology.

During the meeting, principal officials of the Bureau of Biology recognized the Association’s achievements in platform construction and put forward guidance for future work. They stressed the need to continuously strengthen Party‑building leadership, deepen medical‑engineering integration and innovation, precisely align with industrial demands, and boost the high‑quality development of the biomedicine industry in Chengdu High‑tech Zone.

Leaders of Chengdu Xingu Investment Group Co., Ltd. stated that the Group would give full play to its park carrier advantages, fully support platform implementation and industrial services, and jointly fuel the growth of the regional biomedicine industry.

Principal representatives of Chengdu High‑tech Medical Association remarked that taking this research visit as an opportunity, the Association will strive to build a one‑stop comprehensive service platform for medical innovation and translation, further enhance its capacity for integrated medical‑engineering services, and make greater contributions to the development of the regional biomedicine industry.